Skip to main content
Equibles

MORGAN STANLEY

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,356
-$11,831 QoQ
Shares Held
1,671
-84.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 13% Shared 0% None 87%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $3,507,498,556 across 77 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #66 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 8,878,849 $638,034,078
2 HIMS
Hims & Hers Health, Inc.
 7,152,498 $247,977,102
3 VTRS
Viatris Inc
 15,128,899 $240,246,911
4 UTHR
UNITED THERAPEUTICS Corp
 436,699 $236,616,614
5 TEVA
Teva Pharmaceutical Industries Ltd
 6,968,719 $236,100,195
6 NBIX
Neurocrine Biosciences Inc
 1,318,607 $222,238,016
7 ELAN
Elanco Animal Health Inc
 7,854,362 $193,295,842
8 LNTH
Lantheus Holdings, Inc.
 1,726,303 $191,516,050

All Filings in BTAIQ

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,356 1,671
2026-03-31 $14,187 10,588
2025-06-30 $2,858 1,580
2025-03-31 $3,583 1,766
2024-12-31 — 25,796
2024-09-30 — 40,614
2024-06-30 — 116,563
2024-03-31 — 222,299
2023-12-31 — 191,754
2023-09-30 — 203,275
2023-06-30 — 92,867
2023-03-31 — 130,089
2022-12-31 — 124,997
2022-09-30 — 254,742
2022-06-30 — 226,842
2022-03-31 — 211,016
2021-12-31 — 234,727
2021-09-30 — 120,740
2021-06-30 — 119,262
2021-03-31 — 24,265
2020-12-31 — 22,441
2020-09-30 — 17,917
2020-06-30 — 7,315
2020-03-31 — 4,463